IGF2R and neoplasm: In particular, IGFBPs and IGF2R provide two separate mechanisms to regulate IGF2 bioavailability and have each been suggested as a potential tumor suppressor [21–23]; however, it remains unclear which plays the dominant role in regulating IGF2 activity in tumors.